Lamers M, Mykytyn A, Breugem T, Wang Y, Wu D, Riesebosch S, et al. Human airway cells prevent SARS-CoV-2 multibasic cleavage site cell culture adaptation. elife. 2021;10: pubmed publisher

Palermo E, Alexandridi M, Di Carlo D, Muscolini M, Hiscott J. Virus-like particle - mediated delivery of the RIG-I agonist M8 induces a type I interferon response and protects cells against viral infection. Front Cell Infect Microbiol. 2022;12:1079926 pubmed publisher

Oh C, Nakamura T, Beutler N, Zhang X, Pi xf1 a Crespo J, Talantova M, et al. Targeted protein S-nitrosylation of ACE2 inhibits SARS-CoV-2 infection. Nat Chem Biol. 2022;: pubmed publisher

Costa A, Lemes R, Bartolomeo C, Nunes T, Pereira G, Oliveira R, et al. Overexpression of estrogen receptor GPER1 and G1 treatment reduces SARS-CoV-2 infection in BEAS-2B bronchial cells. Mol Cell Endocrinol. 2022;558:111775 pubmed publisher

Kalejaiye T, Bhattacharya R, Burt M, Travieso T, Okafor A, Mou X, et al. SARS-CoV-2 Employ BSG/CD147 and ACE2 Receptors to Directly Infect Human Induced Pluripotent Stem Cell-Derived Kidney Podocytes. Front Cell Dev Biol. 2022;10:855340 pubmed publisher

Jang K, Kaczmarek M, Dallari S, Chen Y, Tada T, Axelrad J, et al. Variable susceptibility of intestinal organoid-derived monolayers to SARS-CoV-2 infection. PLoS Biol. 2022;20:e3001592 pubmed publisher

Bartolomé A, Liang J, Wang P, Ho D, Pajvani U. Angiotensin converting enzyme 2 is a novel target of the γ-secretase complex. Sci Rep. 2021;11:9803 pubmed publisher